Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy: Results from the prospective multi-center SENTINA trial. This is an ASCO Meeting Abstract ...

According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), axillary lymphadenopathy after a COVID-19 vaccine booster dose has a mean time to resolution of 102 days ...

Targeted axillary dissection (TAD) is a relatively new breast cancer procedure. It allows surgical oncologists to specifically locate a lymph node that contained cancer before chemotherapy, remove it ...

Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant chemotherapy, ...

Response-guided axillary treatment using an approach known as the MARI protocol can safely spare many women with node-positive breast cancer from axillary lymph node dissection (ALND) after ...

Axillary lymph node dissection (ALND) is a procedure to remove lymph nodes in the underarm area when breast cancer has spread, aiming to prevent further spread and recurrence. The procedure involves ...

Fat-enlarged axillary nodes on screening mammograms can predict the risk for cardiovascular disease (CVD), according to a study presented at the annual meeting of the American Roentgen Ray Society, ...

An interview with Dr. Muriel Brackstone from London Health Sciences Centre and Dr. Tari King from Dana Farber and Brigham and Women’s Cancer Center, authors on “Management of the Axilla in Early-Stage ...

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most cases, continuing a trend toward less ...